Benign breast disease
Benign breast diseases are the breast diseases in which malignant cells are not present in the breast or, if present, do not spread from the epithelial glands to the deeper layers.
There are two transitional units on the border between benign and malignant lesions: atypical hyperplasia and carcinoma in situ. Due to the epithelial cells from which the changes develop, we distinguish between ductal and lobular types. While atypical ductal hyperplasia (ADH) differs a lot from ductal carcinoma in situ (DCIS) that ADH is classified as a benign disease (only with an increased risk of invasive cancer) and DCIS directly between malignant lesions, the boundary between atypical lobular hyperplasia (ALH) and lobular carcinoma in situ(LCIS) was determined very artificially and does not indicate either biological behavior or prognosis and ALH and LCIS do not differ in therapeutic approach either. Therefore, today ALH and LCIS are combined into one nosological unit as lobular neoplasia.
Distribution[edit | edit source]
They are divided into four groups according to the risk of developing invasive cancer in the field of the diagnosed disease[1].
Non-proliferative lesions[edit | edit source]
These include epithelial metaplasia , cysts , papilloma , fibroadenoma , adenosis and mild and moderate epithelial hyperplasia ..
Epithelial metaplasia is the change from a fully differentiated epithelium to another fully differentiated epithelium and is very common in breasts. (True metaplastic cancer is very rare.)
The cysts themselves are benign in nature, however the discovered intracystic formation is an indication for biopsy[1].
The relative risk of developing invasive cancer is not increased in these lesions[1].
Proliferating lesions without atypia[edit | edit source]
These are severe epithelial hyperplasia, multiple papillomatosis and perhaps sclerosing adenosis.
The relative risk of developing invasive cancer is 1.5–2[1].
Proliferating lesions with atypia[edit | edit source]
It is atypical ductal hyperplasia . The relative risk of developing invasive cancer is 4-6[1].
Lobular neoplasia[edit | edit source]
It is an umbrella term for lobular carcinoma in situ and atypical lobular neoplasia (see above). The relative risk of developing invasive cancer is 6-12[1].
Links[edit | edit source]
Related articles[edit | edit source]
Reference[edit | edit source]
- ROB, Lukáš, Alois MARTAN and Karel CITTERBART. Gynecology. 2nd edition. Prague: Galén, 2008. 390 pp. 251–267. ISBN 978-80-7262-501-7
